Inflammatory Cardiomyopathy Baseline Cohort (SFB/TR19)

Completed

• Conditions: Cardiomyopathies; Heart Failure

• Registration Number: NCT02970227
• Lead Sponsor: University Medicine Greifswald

Brief Summary

cohort of cardiomyopathy patients (suspected or validated inflammatory cardiomyopathy) recruited at baseline by the SFB-TR19 project. Standardized protocols used for the assessment of medical history and examinations, laboratory biomarkers, and the collection of various biosamples for biobanking purposes.

Detailed Description

Not available

Study Timeline

• Study Start: 2004-01
• Primary Completion: 2015-06
• Study Completion: 2015-06
• Status Verified: 2016-11
• Study First Submitted: 2016-11-09
• Study First Submitted QC: 2016-11-17
• Study First Posted: 2016-11-21
• Last Update Submitted: 2016-11-21
• Last Update Posted: 2016-11-22

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 920

Inclusion Criteria

• suspected inflammatory cardiomyopathy at baseline

Exclusion Criteria

• none

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cardiovascular events	1-year follow-ups	Hospitalization (HF based. all-cause), interventions (ICD, pacemaker), myocardial infarction

Secondary Outcome Measures

Name	Time	Method
QOL	1-year follow-ups	Quality of life by questionnaire (Minnesota Living with HF questionnaire)
Mortality	1-year follow-ups	Mortality (HF-related, CVD, all-cause)
LVEF	1-year follow-ups	Left ventricular ejection fraction at time of follow-up
VO2peak	1-year follow-ups	Exercise capacity by CPET

Trial Locations

Locations (1)

Department of Internal Medicine B, University Medicine Greifswald; 🇩🇪 Greifswald, MV, Germany